Understanding Uterine Fibroid Embolization: The Incomplete Treatment Most Women Should Know
Every year, countless women find themselves recommended for a treatment known as Uterine Fibroid Embolization, or UFE, under the impression that it will resolve their fibroid issues. However, this procedure, while frequently touted as minimally invasive, falls short of what many believe it does. Rather than eliminating fibroids altogether, UFE merely shrinks them slightly, and for many women, the relief is minimal or short-lived. The situation is exacerbated given that fibroids are incredibly common, affecting about 80% of women by the time they reach 50 years old. With such prevalence, it's crucial to understand what UFE truly offers versus the real needs women may have regarding their reproductive health.
In the words of Dr. Natalya Danilyants, a board-certified GYN surgeon and co-founder of the Center for Innovative GYN Care (CIGC), ‘UFE may shrink fibroids slightly, but it rarely makes a meaningful difference—especially with large or complex cases.’ What many aren't informed about is that the fibroids remain unchanged in the body, and the troublesome symptoms—pain, pressure, and heavy bleeding—might persist or even worsen because the underlying issue isn't addressed.
Moreover, there are significant implications that come with opting for UFE. It is not only ineffective for larger or more intricate fibroids, but it also can impair blood flow to critical areas such as the uterus and ovaries, which can negatively impact fertility. This becomes a severe concern for those hoping to conceive in the future. Additionally, conditions like endometriosis or adenomyosis, which often accompany fibroid growth, go undiagnosed with UFE, as the procedure does not cater to or recognize these prevalent issues.
At CIGC, we believe in offering women real solutions and transparency in their treatment options. For over 18 years, we've specialized in minimally invasive surgical procedures that effectively remove fibroids—regardless of their size or complexity. Our procedures, such as the LAAM® myomectomy and DualPortGYN®, entail only two small incisions, leading to a significantly shorter recovery period, allowing patients to resume normal activities often within just a week.
LAAM® Myomectomy is a fertility-sparing surgery, which could enhance the chances of conception for women, as it definitively removes fibroids rather than just managing symptoms associated with them.
The DualPortGYN® technique employs advanced laparoscopic methods to achieve uterine or fibroid removal, greatly minimizing patient discomfort and downtime. Additionally, with both procedures, patients can expect to be home the same day and return to work within a fortnight.
What sets CIGC apart from the conventional approach of UFE is our comprehensive care model. Not only can our surgeons accurately diagnose and remove endometriosis, cysts, or adenomyosis during the procedure, but they also send all examined tissue to pathology for detailed testing. This ensures patients leave the operating room fully informed about their health status regarding reproductive concerns.
Some women may find themselves dismissed when expressing concerns about the severity of their fibroids, or they may be channeled toward the catch-all treatment of UFE. However, it’s vital to consider personalized care. If you've been given generic recommendations, take action now. It's time to consult a trained gynecologic surgeon to explore safer, more effective options that address your specific health needs.
Dr. Danilyants summarizes, ‘Women deserve far more than just to manage their symptoms. They’re entitled to proper validation, empathy, and practical solutions.’ Our focus at CIGC remains steadfast on just that—empowering women through informed choices about their healthcare.
In conclusion, UFE is not the be-all-end-all solution for fibroids. It presents an incomplete care options rather than addressing the root causes. The Center for Innovative GYN Care stands as a testament to advancing women’s healthcare, advocating for transparent and effective treatment pathways that prioritize patient well-being above all else. For more information on our groundbreaking procedures, visit our website or follow us on our social platforms.
In the words of Dr. Natalya Danilyants, a board-certified GYN surgeon and co-founder of the Center for Innovative GYN Care (CIGC), ‘UFE may shrink fibroids slightly, but it rarely makes a meaningful difference—especially with large or complex cases.’ What many aren't informed about is that the fibroids remain unchanged in the body, and the troublesome symptoms—pain, pressure, and heavy bleeding—might persist or even worsen because the underlying issue isn't addressed.
Moreover, there are significant implications that come with opting for UFE. It is not only ineffective for larger or more intricate fibroids, but it also can impair blood flow to critical areas such as the uterus and ovaries, which can negatively impact fertility. This becomes a severe concern for those hoping to conceive in the future. Additionally, conditions like endometriosis or adenomyosis, which often accompany fibroid growth, go undiagnosed with UFE, as the procedure does not cater to or recognize these prevalent issues.
At CIGC, we believe in offering women real solutions and transparency in their treatment options. For over 18 years, we've specialized in minimally invasive surgical procedures that effectively remove fibroids—regardless of their size or complexity. Our procedures, such as the LAAM® myomectomy and DualPortGYN®, entail only two small incisions, leading to a significantly shorter recovery period, allowing patients to resume normal activities often within just a week.
LAAM® Myomectomy is a fertility-sparing surgery, which could enhance the chances of conception for women, as it definitively removes fibroids rather than just managing symptoms associated with them.
The DualPortGYN® technique employs advanced laparoscopic methods to achieve uterine or fibroid removal, greatly minimizing patient discomfort and downtime. Additionally, with both procedures, patients can expect to be home the same day and return to work within a fortnight.
What sets CIGC apart from the conventional approach of UFE is our comprehensive care model. Not only can our surgeons accurately diagnose and remove endometriosis, cysts, or adenomyosis during the procedure, but they also send all examined tissue to pathology for detailed testing. This ensures patients leave the operating room fully informed about their health status regarding reproductive concerns.
Some women may find themselves dismissed when expressing concerns about the severity of their fibroids, or they may be channeled toward the catch-all treatment of UFE. However, it’s vital to consider personalized care. If you've been given generic recommendations, take action now. It's time to consult a trained gynecologic surgeon to explore safer, more effective options that address your specific health needs.
Dr. Danilyants summarizes, ‘Women deserve far more than just to manage their symptoms. They’re entitled to proper validation, empathy, and practical solutions.’ Our focus at CIGC remains steadfast on just that—empowering women through informed choices about their healthcare.
In conclusion, UFE is not the be-all-end-all solution for fibroids. It presents an incomplete care options rather than addressing the root causes. The Center for Innovative GYN Care stands as a testament to advancing women’s healthcare, advocating for transparent and effective treatment pathways that prioritize patient well-being above all else. For more information on our groundbreaking procedures, visit our website or follow us on our social platforms.
Topics Health）
【About Using Articles】
You can freely use the title and article content by linking to the page where the article is posted.
※ Images cannot be used.
【About Links】
Links are free to use.